Streptolysin O Promotes Group A Streptococcus Immune Evasion by Accelerated Macrophage Apoptosis
Article 2008 en
Authors
AT
Anjuli M. Timmer
JT
John C. Timmer
MP
Morgan A. Pence
Abstract
1 min read
Group A Streptococcus (GAS) is a leading human bacterial pathogen capable of producing invasive infections even in previously healthy individuals. As frontline components of host innate defense, macrophages play a key role in control and clearance of GAS infections. We find GAS induces rapid, dose-dependent apoptosis of primary and cultured macrophages and neutrophils. The cell death pathway involves apoptotic caspases, is partly dependent on caspase-1, and requires GAS internalization by the phagocyte. Analysis of GAS virulence factor mutants, heterologous expression, and purified toxin studies identified the pore-forming cytolysin streptolysin O (SLO) as necessary and sufficient for the apoptosis-inducing phenotype. SLO-deficient GAS mutants induced less macrophage apoptosis in vitro and in vivo, allowed macrophage cytokine secretion, and were less virulent in a murine systemic infection model. Ultrastructural evidence of mitochondrial membrane remodeling, coupled with loss of mitochondrial depolarization and cytochrome c release, suggests a direct attack of the toxin initiates the intrinsic apoptosis pathway. A general caspase inhibitor blocked SLO-induced apoptosis and enhanced macrophage killing of GAS. We conclude that accelerated, caspase-dependent macrophage apoptosis induced by the pore-forming cytolysin SLO contributes to GAS immune evasion and virulence.
Magali Bébien, Mary E. Hensler, Suzel Davanture, Li‐Chung Hsu, Michael Karin, Jin Mo Park, Lena Alexopoulou, George Y. Liu, Victor Nizet, Toby Lawrence
Helen M. Marriott, Colin D. Bingle, Robert C. Read, Karen Braley, Guido Guido Kroemer, Paul G. Hellewell, Ruth W. Craig, Moira K. B. Whyte, David H. Dockrell
Helen M. Marriott, Colin D. Bingle, Robert C. Read, Karen Braley, Guido Guido Kroemer, Paul G. Hellewell, Ruth W. Craig, Moira K. B. Whyte, David H. Dockrell
Discussion(0)
No comments yet. Be the first to comment.